Leading chip stocks in the US stock market generally fell, with TSMC closing at US $77.94, down 2.42%, NVIDIA closing at US $434.00, down 2.82%, Intel closing at US $48.19, down 2.09%, Broadcom closing at US $324.03, down 1.02%, Qualcomm closing at US $108.83, up 2.32%, Texas Instruments closing at US $136.04, up 0.47%, amd closing at US $76.88, down 6.52%, and applied materials Materials companies fell 1.20%; Meguiar technology fell 2.83%.
Most of the major Chinese stocks listed in the United States fell, with Alibaba closing at $248.42, up 0.12%; Jingdong closing at $61.18, down 0.50%; Baidu closing at $124.60, down 0.37%; pinduoduo closing at $87.27, down 0.30%; bilibilibili closing at $40.34, down 1.61%; tal closing at $74.89, up 1.20%; iqiyi closing at $22.11, down 1.73% Follow who learn to close at 98.02 US dollars, up 1.51%; micro blog to 35.10 US dollars, down 0.74%; Sina down 0.48%; Sohu up 1.09%; Sogou up 0.00%; Ctrip up 0.92%; 51job down 3.36%; car home up 0.39%; 58 city down 0.05%; Weilai down 8.59%; Jinshan cloud down 3.06%, ideal car down 2.56%.
Earlier in the day, both the standard and Dow were higher. Russian President Vladimir Putin has announced that the countrys regulators have approved the worlds first new crown vaccine. Despite doubts about Russias rapid development of a new, safe vaccine, the news has sparked investor optimism.
A senior executive of Johnson & Johnson also told the media that if the companys candidate new crown vaccine proves successful, it is expected to produce 1 billion doses next year.
The market is looking forward to a better future, Jeff Buchbinder, equity strategist at financial services firm LPL financial, said in a report. Although it is not yet certain when it will come, the stock market is expressing confidence that the emergence of one or more vaccines will eventually end the epidemic.
Over the weekend, Goldman Sachs, an investment bank, raised its forecast for U.S. economic growth and predicted that the United States would approve at least one vaccine by the end of this year, with widespread vaccination by the second quarter of next year.
At the same time, the uncertain future of an outbreak stimulus program designed to support Americans during the outbreak continues to unsettle investors.
U.S. Treasury Secretary Steven mnuchin said on Monday that the White House is open to resuming negotiations with Democrats on new coronavirus aid and opening more relief funds to reach a compromise. However, Mitch McConnell, the majority leader in the US Senate, said on Tuesday that talks with Democrats were at an impasse.
Source: Wang Fengzhi, editor in charge of Netease science and Technology Report_ NT2541